|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6,405.00 JPY | +0.68% |
|
-3.65% | -19.34% |
| 13/04 | Cosmos Pharmaceutical's Nine-Month Profit Rises 1.8% | MT |
| 13/04 | Cosmos Pharmaceutical Corporation Provides Consolidated Earnings Guidance for the Full Year of Fiscal Year Ending May 31, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Retail - Drugs with Grocery
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 312.18Cr | |||||
| 633.29Cr | |||||
| 327.39Cr | |||||
| 275.14Cr | |||||
| 216.42Cr | |||||
| 130.19Cr | - | - | - | - | - |
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
